Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G STOCK

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Transplantation|May 16, 1998
Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporineC E Freise, C A Galbraith, B J Nikolai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2007
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsL A Frassetto, M Browne, A Cheng, et al.
Transplantation Proceedings|February 1, 1993
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicityP G Stock, N L Ascher, R W Osorio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2015
Effect of Immigration Status on Outcomes in Pediatric Kidney Transplant RecipientsM E McEnhill, J L Brennan, E Winnicki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 21, 2000
Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicatedG J Chang, H D Mahanty, D Quan, et al.
Clinical Transplantation|January 11, 2000
A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft functionG J Chang, H D Mahanty, F Vincenti, et al.
Clinical Transplantation|April 1, 1995
Long-term outcome in kidney transplant patients with hepatitis C (HCV) infectionS L Orloff, C A Stempel, T L Wright, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal diseaseK A Benedict, S Moassesfar, S Adi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2020
OPTN/SRTR 2018 Annual Data Report: PancreasR Kandaswamy, P G Stock, S K Gustafson, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Transplantation|May 16, 1998
Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporineC E Freise, C A Galbraith, B J Nikolai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 5, 2014
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsP G Stock, B Barin, H Hatano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2007
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipientsL A Frassetto, M Browne, A Cheng, et al.
Transplantation Proceedings|February 1, 1993
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicityP G Stock, N L Ascher, R W Osorio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2015
Effect of Immigration Status on Outcomes in Pediatric Kidney Transplant RecipientsM E McEnhill, J L Brennan, E Winnicki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 21, 2000
Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicatedG J Chang, H D Mahanty, D Quan, et al.
Clinical Transplantation|January 11, 2000
A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft functionG J Chang, H D Mahanty, F Vincenti, et al.
Clinical Transplantation|April 1, 1995
Long-term outcome in kidney transplant patients with hepatitis C (HCV) infectionS L Orloff, C A Stempel, T L Wright, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal diseaseK A Benedict, S Moassesfar, S Adi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2020
OPTN/SRTR 2018 Annual Data Report: PancreasR Kandaswamy, P G Stock, S K Gustafson, et al.
Pageof 10